20-59773348-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_080672.5(PHACTR3):c.821C>T(p.Thr274Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00012 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T274K) has been classified as Uncertain significance.
Frequency
Consequence
NM_080672.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHACTR3 | NM_080672.5 | c.821C>T | p.Thr274Ile | missense_variant | 6/13 | ENST00000371015.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHACTR3 | ENST00000371015.6 | c.821C>T | p.Thr274Ile | missense_variant | 6/13 | 1 | NM_080672.5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000187 AC: 47AN: 251346Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135856
GnomAD4 exome AF: 0.000116 AC: 169AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.000106 AC XY: 77AN XY: 727238
GnomAD4 genome AF: 0.000164 AC: 25AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.821C>T (p.T274I) alteration is located in exon 6 (coding exon 6) of the PHACTR3 gene. This alteration results from a C to T substitution at nucleotide position 821, causing the threonine (T) at amino acid position 274 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at